| Issue |
Section |
Title |
File |
| Vol 16, No 4 (2017) |
Статьи |
Blinatumomab therapy for relapsed and refractory acute lymphoblastic leukemia |
(Rus)
|
| Vol 16, No 1 (2017) |
Статьи |
Herpesvirus infection following allogenic hematopoietic stem cell transplantation with TCRαβ and CD19 depletion: risk factors and outcome |
(Rus)
|
| Vol 14, No 1 (2015) |
IMAGES |
CNS relapse with spinal cord involvement after hematopoietic stem cell transplantation in a patient with acute lymphoblastic leukemia |
(Rus)
|
| Vol 17, No 2 (2018) |
PROMISING STUDIES |
Low dose donor memory T-cell infusion after TCR alpha/beta depleted stem cell transplantation for patients with malignant disorders |
(Rus)
|
| Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
Late effects after treosulfan- and busulfan-based myeloablative conditioning for allogeneic HSCT in children with malignant diseases: a comparative study |
(Rus)
|
| Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
The Influence of Natural Killer Cell Alloreactivity on the Outcome of α/βTCR/CD19+ depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia |
(Rus)
|
| Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
Low doses of decitabine for prevention of relapse after allogeneic hematopoietic stem cell transplantation: a single-center experience |
(Rus)
|
| Vol 18, No 1 (2019) |
PROMISING STUDIES |
First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 18, No 2 (2019) |
PROMISING STUDIES |
αβ-T-cell-depleted haploidentical hematopoietic stem cell transplantation in children with chemorefractory acute myeloid leukemia |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
Evaluation of abatacept for GVHD prophylaxis in patients with non-malignant diseases after hematopoietic stem cell transplantation |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
The thoracic air-leak syndrome (TALS): the frequency of occurrence and radiological signs in the structure of late non-infectious lung lesions in children after the allogeneic HSСT |
(Rus)
|
| Vol 18, No 3 (2019) |
PROMISING STUDIES |
Low-dose infusions of CD45RA depleted donor lymphocytes after TCRα/β-depleted transplantation in patients with non-malignant disorders |
(Rus)
|
| Vol 19, No 1 (2020) |
PROMISING STUDIES |
The results of treatment in children with AML and initial hyperleucocytosis according to the AML-MM-2006 Protocol |
(Rus)
|
| Vol 19, No 2 (2020) |
ПЕРЕДОВАЯ СТАТЬЯ |
Hematopoietic stem cell transplantation in children in Russia: a brief overview of activity in 2015–2018 |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
Hematopoietic stem cell transplantation with TCRαβ+/CD19+ - graft depletion for hemophagocytic lymphohistiocytosis |
(Rus)
|
| Vol 19, No 2 (2020) |
CLINICAL OBSERVATIONS |
The treatment of multiple organ dysfunction syndrome caused by gram-negative sepsis in a patient with neutropenia after allogeneic hematopoietic stem cell transplantation: a case report |
(Rus)
|
| Vol 19, No 2 (2020) |
LITERATURE REVIEW |
Hematopoietic stem cell transplantation in patients with transfusion-dependent β-thalassemia. Review article |
(Rus)
|
| Vol 19, No 3 (2020) |
ORIGINAL ARTICLES |
Haematological complications of X-linked lymphoproliferative syndrome type 1 and 2 |
(Rus)
|
| Vol 19, No 4 (2020) |
ORIGINAL ARTICLES |
Allogeneic hematopoietic stem cell transplantation for alveolar rhabdomyosarcoma: the first clinical experience of haploidentical transplantation |
(Rus)
|
| Vol 20, No 2 (2021) |
ПЕРЕДОВАЯ СТАТЬЯ |
The safety and effctiveness of donor memory T lymphocyte infusions after hematopoietic stem cell transplantation with ab T cell depletion platform in children with acute leukemia |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
Treosulfan-based conditioning for hematopoietic stem cell transplantation in patients with Diamond–Blackfan anemia |
(Rus)
|
| Vol 20, No 2 (2021) |
CLINICAL OBSERVATIONS |
CNS relapse of B-lymphoblastic lymphoma after allogeneic hematopoietic stem cell transplantation: therapy with donor CD19-specific CAR-T cells |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol |
(Rus)
|
| Vol 21, No 2 (2022) |
ORIGINAL ARTICLES |
Experience in the use of 5-azacytidine, bortezomib and valproic acid for the prevention of leukemia relapses in children after ab-T cell-depleted hematopoietic stem cell transplantation |
(Rus)
|
| Vol 21, No 2 (2022) |
SCHOOL ON TRANSPLANTATION AND CELLUL AR THERAPY |
Hematopoietic stem cell transplantation: indications, types of transplantations, 132 donor selection |
(Rus)
|
| Vol 21, No 3 (2022) |
SCHOOL OF IMMUNOLOGY – EXPERT OPINION |
Clinical characteristics of patients with the SAMD9/SAMD9L gene defects |
(Rus)
|
| Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
Acute lymphoblastic leukemia with the t(17;19) translocation: hope has appeared! Multimodal immunotherapy in a 3-year-old child with refractory disease: a case report |
(Rus)
|
| Vol 21, No 3 (2022) |
SCHOOL ON TRANSPLANTATION AND CELLUL AR THERAPY |
Hematopoietic stem cell transplantation: preparation treatment, graft characteristics, criteria of engraftment, and supportive care |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience |
(Rus)
|
| Vol 22, No 2 (2023) |
CLINICAL OBSERVATIONS |
Daratumumab in the treatment of pure red cell aplasia after pediatric allogeneic stem cell transplantation |
(Rus)
|
| Vol 22, No 2 (2023) |
ORIGINAL ARTICLES |
The effectiveness of the respiratory muscles in children with oncohematological diseases after hematopoietic stem cell transplantation |
(Rus)
|
| Vol 22, No 3 (2023) |
ORIGINAL ARTICLES |
The results of therapy with venetoclax, daratumumab and plerixafor as part of the conditioning regimen in chemotherapy-refractory acute leukemia in children |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
The results of allogenic hematopoietic stem cell transplantation in primary immunodeficiencies with hemophagocytic lymphohistiocytosis |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
Comparative characterization of the cell composition and functional properties of anti-CD19 biomedical cell products manufactured using the CliniMACS Prodigy and G-Rex platforms |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
The use of thiotepa in reduced toxicity conditioning regimens before hematopoietic stem cell transplantation in primary immunodeficiencies |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
Allogeneic hematopoietic stem cell transplantation outcomes in pediatric patients with refractory acute myeloid leukemia |
(Rus)
|
| Vol 23, No 3 (2024) |
ORIGINAL ARTICLES |
Quality of life and subjective well-being of children and caregivers at different stages of allogeneic hematopoietic stem cell transplantation |
(Rus)
|
